Type 1 diabetes patients over the age of 26 lose their right to reimbursement for insulin pumps and continuous glycemic monitoring (CGM) systems. This means that patients have to cover the full cost of therapy, which for many is a financial barrier preventing the continued use of these modern treatments. In response to the Ombudsman's intervention, the Health Ministry said what plans it has to expand the group of those eligible for reimbursement.
Reimbursement only until age 26 - what's next?
Currently in Poland, reimbursement of insulin pumps is covered for children and young adults up to the age of 26. After that age, patients have to bear the full cost of purchasing the pump, which can reach tens of thousands of zlotys. For many patients, this means giving up this method of treatment and returning to multiple insulin injections, which in their case can lead to worsening diabetes control and an increased risk of complications.
A similar situation a...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
